OTCMKTS:MTACU MedTech Acquisition (MTACU) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free MTACU Stock Alerts $11.35 +1.85 (+19.47%) (As of 08/10/2023) Add Compare Share Share Today's Range$10.00▼$11.3550-Day Range$11.35▼$11.3552-Week Range$9.23▼$11.43Volume1,900 shsAverage Volume585 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesStock AnalysisHeadlines Get MedTech Acquisition alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About MedTech Acquisition Stock (OTCMKTS:MTACU)MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States. The company was incorporated in 2020 and is based in Greenwich, Connecticut. MedTech Acquisition Corporation operates as a subsidiary of Medtech Acquisition Sponsor LLC.Read More MTACU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MTACU Stock News HeadlinesApril 15, 2024 | bizjournals.comMeet FloodGate Medical, a 2024 Best Places to Work honoreeApril 12, 2024 | finance.yahoo.comJPMorgan Chase (JPM) Q1 2024 Earnings Call TranscriptApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 5, 2024 | seekingalpha.comInspire Medical Systems: A Potential Example Of Market MispricingFebruary 26, 2024 | forbes.comInvestment News: Retail Investors Able To Participate In Primary Gilts MarketFebruary 8, 2024 | news.yahoo.comMedical device maker Baxter beats sales and profit estimates on strong demandFebruary 6, 2024 | markets.businessinsider.comRevolutionary AI-Driven Medtech Platform Changes the Way Patients Receive Quality Healthcare in the UKJanuary 25, 2024 | news.yahoo.comMedStar call volume increases, resources stretched to meet demand for ambulances: reportApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.January 23, 2024 | bizjournals.comSpurred by Abiomed deal, J&J medtech business grows in 2023January 8, 2024 | cnbc.comMedical device maker Boston Scientific to buy Axonics for $3.7 billionDecember 16, 2023 | investing.comTriSalus Life Sciences Inc (TLSI)December 13, 2023 | msn.comThe 8 Best Retirement Stocks To Buy and Hold for 2023December 12, 2023 | finance.yahoo.comMaaT Pharma to Host Virtual KOL Event on MaaT013 and MaaT033 Following ASH 2023 PresentationsDecember 2, 2023 | msn.comJohnson & Johnson MedTech acquires heart implant company Laminar for $400mNovember 28, 2023 | forbes.comInvestment News: Regulator To Crack Down On Product ‘Greenwashing’October 28, 2023 | finance.yahoo.comGentex Corporation (NASDAQ:GNTX) Q3 2023 Earnings Call TranscriptOctober 28, 2023 | msn.comApple, Fed Meeting, Caterpillar, Jobs Report; Investing Action PlanOctober 12, 2023 | markets.businessinsider.comXtant Medical Highlights Growing Product Portfolio at NASS 2023August 15, 2023 | finance.yahoo.comMagnetar Financial LLC Acquires Shares in MedTech Acquisition CorpAugust 10, 2023 | finance.yahoo.comTriSalus Life Sciences Completes Merger with MedTech Acquisition CorporationJuly 28, 2023 | finance.yahoo.comMagnetar Financial LLC Reduces Stake in MedTech Acquisition CorpJuly 26, 2023 | msn.comJ&J's Medtech Business Is Soaring. Time to Buy the Stock?June 12, 2023 | finance.yahoo.comTriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual MeetingFebruary 14, 2023 | msn.comCork medtech company acquired by German firmDecember 7, 2022 | finance.yahoo.comMedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of StockholdersNovember 15, 2022 | msn.comMedtech giant Cordis acquires MedAlliance in a US $1.1Billion dealSee More Headlines Receive MTACU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedTech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinancial Services Industry Shell Companies Sub-IndustryN/A Current SymbolOTCMKTS:MTACU CUSIPN/A CIK1826667 WebN/A Phone908-391-1288FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Christopher C. Dewey (Age 79)CEO & Director Mr. David J. Matlin J.D. (Age 61)CFO & Director Mr. Robert H. Weiss J.D. (Age 64)Chief Admin. Officer & Sec. Key Competitors99 Acquisition GroupNASDAQ:NNAGU99 Acquisition GroupNASDAQ:NNAGWA SPAC I AcquisitionNASDAQ:ASCAUA SPAC I AcquisitionNASDAQ:ASCAWA SPAC II AcquisitionNASDAQ:ASCBUView All Competitors MTACU Stock Analysis - Frequently Asked Questions How have MTACU shares performed in 2024? MedTech Acquisition's stock was trading at $11.35 on January 1st, 2024. Since then, MTACU stock has increased by 0.0% and is now trading at $11.35. View the best growth stocks for 2024 here. How do I buy shares of MedTech Acquisition? Shares of MTACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MTACU) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedTech Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
